Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9139530
SERIAL NO

14272692

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • VERTEX PHARMACEUTICALS INCORPORATED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Connelly, Patrick R Harvard, US 78 6090
Costache, Adriana Cambridge, US 11 633
Feng, Yushi Zionsville, US 12 860
Gong, Yuchuan Waukegan, US 31 576
Hurter, Patricia Harvard, US 22 1132
Krawiec, Mariusz Marlborough, US 49 2928
Rowe, William Medford, US 40 1871
Trudeau, Martin Shannon, US 33 1299
Young, Christopher R Waltham, US 21 1791

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 22, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00